Pharmafile Logo
Pharmafocus logo
Advanced Search

Lundbeck

Showing 15 posts of 69 posts found.

brintellix

FDA issues CRL for Takeda/Lundbeck’s Brintellix

March 29, 2016
Manufacturing and Production, Research and Development Lundbeck, Takeda, brintellix

Takeda and Lundbeck have received a complete response letter from the US Food and Drug Administration (FDA) for the supplemental …

News
Lundbeck HQ

Lundbeck gets go-ahead for US and EU licence expansions

February 4, 2016
Medical Communications, Sales and Marketing Abilify, EMA, FDA, Lundbeck, Otsuka, Takeda, aripiprazole, brintellix, vortioxetine

Lundbeck has earned two recommendations from regulatory committees of the FDA and the EMA, which both recommended the company’s drugs …

News

Lundbeck sheds 1,000 jobs in £284 million restructure

August 20, 2015
Manufacturing and Production, Sales and Marketing Lundbeck, generics, job losses, patents, redundancies, restructure, restructuring

Lundbeck is cutting a thousand jobs globally as part of a restructuring programme to significantly lower its cost and focus …

News
Rexulti (brexpiprazole)

FDA approves Lundbeck and Otsuka’s Rexulti for depression

July 14, 2015
Sales and Marketing FDA, Lundbeck, Otsuka, Rexulti, US, brexpiprazole, depression, major depressive disorder, schizophrenia

Lundbeck and Otsuka have gained a yes vote from the FDA for their jointly-marketed antidepressant, Rexulti. The US regulator approved …

News
screen_shot_2015-05-06_at_11

Lundbeck gains new chief executive from Novo Nordisk

May 6, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kåre Schultz, Lundbeck, Novo Nordisk, Rebien Sorensen

Danish pharma giant Lundbeck has appointed Kåre Schultz as its new president and chief executive. Schultz (pictured) will take up …

Appointment
Campbell image

Changing our minds about depression

February 9, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Campbell, Lamb, Lundbeck, depression, economist, mind

Alastair Campbell, former Labour spin doctor and depression patient, thinks that mental and physical health should not be seen as …

Feature

Lundbeck scraps stroke drug

December 18, 2014
Research and Development, Sales and Marketing AIS, DIAS, Lundbeck, acute ischemic stroke, desmoteplase, stroke

Lundbeck has stopped development of its investigational stroke drug desmoteplase following disappointing results from its Phase III studies. The DIAS-3 …

News
Selincro image

Lundbeck’s alcohol pill given NICE approval

November 27, 2014
Sales and Marketing Lundbeck, NHS, NICE, alcohol, selincro

NICE has finally approved the use of Selincro (nalmefene) in order to help people who are dependent on alcohol cut …

News
Kofi Annan speaks at the 'global crisis of depression' summit hosted in Lo

Mental and physical health should be treated equally

November 26, 2014
Medical Communications, Research and Development, Sales and Marketing Campbell, Lundbeck, depression, kofi annan, wiinberg

The need for a new approach to depression that gives it equal importance to physical health was the focus of …

News
Ulf Wiinberg image

Lundbeck chief executive resigns amid scandal

November 25, 2014
Medical Communications, Sales and Marketing Björklund, Lundbeck, stratified medical, ulf wiinberg

Ulf Wiinberg has resigned from his chief executive post at Denmark-based pharma giant Lundbeck following a beach of its rules …

News

Lundbeck sales slide as generic competition bites

November 6, 2014
Sales and Marketing Ebixa, Lundbeck, Q3, Xenazine, generic, onfi, sabril

Lundbeck’s sales fell dramatically in the third quarter of 2014 as it struggles with expiring patents, although several of its …

News

FDA accepts new schizophrenia drug filing

September 24, 2014
Sales and Marketing FDA, Lundbeck, Otsuka, brexpiprazole, depression, schizophrenia

The FDA is reviewing Otsuka and Lundbeck’s brexpiprazole for the treatment of schizophrenia and as an adjunctive therapy for the …

News

No silver bullet, but a growing arsenal for pharma comms

September 16, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lundbeck, comms, eyeforpharma, mcm, selincro, tim white

Digital strategies in the pharma industry have predominately been a red herring, focussing too much on the novelty of digital …

Feature
selincro image

NICE ‘yes’ for Selincro

July 10, 2014
Sales and Marketing Lundbeck, NHS, NICE, alcohol, nalmefene, selincro

Lundbeck has received a lift from UK drugs pricing watchdog NICE as it has recommended the firm’s alcohol dependency pill …

News
screen_shot_2014-06-16_at_09

Avillion hires Lundbeck chief executive

June 16, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Avillion, Lundbeck, wiinberg

UK drug development firm Avillion has appointed Lundbeck chief executive Ulf Wiinberg as the chairman of its board of directors. …

Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025